* This field is required

Trichomoniasis

Solutions
Online Inquiry

Trichomoniasis

Trichomoniasis stands as a widespread sexually transmitted infection. Through our innovative strides in trichomoniasis research, we lead the way in crafting state-of-the-art IVD tools to optimize the management of trichomoniasis. Serving as your dependable trichomoniasis diagnostic research collaborator, we deliver unmatched assistance to fulfill your research requirements.

Overview of Trichomoniasis

Trichomoniasis, a common sexually transmitted infection (STI) globally, stems from the protozoan parasite Trichomonas vaginalis. This infection predominantly impacts individuals identified as female at birth. Trichomoniasis frequently presents without symptoms, posing challenges for diagnosis. With about 3.7 million cases documented in the United States, there is a pressing demand for specialized diagnostic solutions to detect this complex disease.

Schematic diagram of the pathogenic behavior of Trichomonas vaginalis.Fig. 1 Pathogenic behaviors of Trichomonas vaginalis. (Mercer, Frances, and Patricia J. Johnson., 2018)

Diagnostic Biomarkers for Trichomoniasis

Trichomoniasis diagnostic biomarkers are essential to achieve early detection, accurate diagnosis, and timely intervention, ultimately improving therapeutic outcomes and reducing transmission rates. Common biomarkers used for trichomoniasis diagnosis are listed below.

DNA

PCR technology that targets specific regions of Trichomonas vaginalis DNA allows for sensitive and specific identification of the parasite. By amplifying and detecting DNA sequences, healthcare providers can confirm active infection.

Antibodies

When exposed to the parasite, the host produces antibodies specific for Trichomonas vaginalis antigens. Detection of these antibodies in serum or other biological specimens can indicate recent or past exposure to the parasite.

Antigens

Specific Trichomonas vaginalis surface antigens, such as P270 and AP65, serve as valuable biomarkers for diagnostic testing. Identification and quantification of these antigens help confirm the presence of Trichomonas vaginalis infection.

IVD Kits for Trichomoniasis

In vitro diagnostic (IVD) kits offer rapid, accurate, and user-friendly solutions for the diagnosis of trichomoniasis. These kits efficiently screen and diagnose trichomoniasis by detecting specific biomarkers associated with Trichomonas vaginalis infection, thereby enabling early detection and timely intervention.

Kits Applications Detection Methods
Trichomonas Vaginalis Antigen Rapid Test Kit Accurate qualitative detection of Trichomonas vaginalis antigen in vaginal swabs. Immunochromatographic Assay
Trichomonas Vaginalis PCR Detection Kit Detection of Trichomonas vaginalis specific DNA. PCR
Trichomonas Vaginalis Antibody Test Kit Qualitative detection of Trichomonas vaginalis antibodies in samples. ELISA

Our Services

Our company specializes in delivering customized IVD solutions for infectious diseases like trichomoniasis. We are dedicated to developing antigen, antibody, DNA, and microbial test kits to facilitate the swift identification and precise detection of trichomoniasis. Leveraging our diagnostic devices, these kits are designed to attain peak levels of specificity, sensitivity, and accuracy in detection.

Additionally, we offer point-of-care testing (POCT) and companion diagnostic development services tailored for trichomoniasis. Our services assist in the creation of portable and easy-to-use IVD tools, enabling swift identification and personalized therapeutics for trichomoniasis.

If you are interested in our services, please feel free to contact us for more details and quotation information of related services.

Reference

  1. Mercer, Frances, and Patricia J. Johnson. "Trichomonas vaginalis: pathogenesis, symbiont interactions, and host cell immune responses." Trends in parasitology 34.8 (2018): 683-693.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.